Colorable Maxxam™ FR Polypropylene Solutions provide cost savings and improve data processing capabilities Engineered Polymer Materials for EV Batteries

Home printer OEM HOME PRINTER OEM R E C Y C L E D H I P S I N J E C T I O N C O V E R O F P R I N T E R • Provide PCR-based colorants for a more sustainable solution • Meet both color and mechanical requirements in PCR materials • Offer user-friendly PCR + Colorants solution to address the batch variance problem of PCR in an economical way • Offered revolutionary supply model of PCR + Colorants, ensuring precise quality and color • Helped customers solve the batch variance problem of PCR in a digital way and shortened the color-matching time with PCR Color Prediction Service • Provided on-site technical support to customer Rejoin PCR Colorants KEY REQUIREMENTS WHY AVIENT? AVIENT SOLUTION PCR BASED COLORANTS + QUALITY LEARN MORE Copyright © 2024, Avient Corporation. https://www.avient.com/products/polymer-colorants/solid-color-masterbatches/rejoin-pcr-colorants Slide 1: Home printer OEM

Rose Vice President, Marketing and Communications Avient Corporation +1 440-930-3162 kyle.rose@avient.com mailto:giuseppe.disalvo@avient.com mailto:kyle.rose@avient.com 6 Attachment 1 Avient Corporation Summary of Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Three Months Ended December 31, Year Ended December 31, 2023 2022 2023 2022 Sales $ 719.0 $ 790.4 $ 3,142.8 $ 3,396.9 Operating income 43.1 0.4 196.8 243.3 Net income (loss) from continuing operations attributable to Avient shareholders 27.8 (17.0) 75.8 82.8 Diluted earnings (loss) per share from continuing operations attributable $ 0.30 $ (0.19) $ 0.83 $ 0.90 Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results. Three Months Ended December 31, 2023 2022 Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1) Net income (loss) from continuing operations attributable to Avient shareholders $ 27.8 $ 0.30 $ (17.0) $ (0.19) Special items, after tax (Attachment 3) 5.4 0.06 38.3 0.42 Amortization expense, after-tax 15.0 0.16 14.6 0.16 Adjusted net income / EPS $ 48.2 $ 0.52 $ 35.9 $ 0.39 (1) Per share amounts may not recalculate from figures presented herein due to rounding Year Ended December 31, 2023 2022 Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1) Net income from continuing operations attributable to Avient shareholders $ 75.8 $ 0.83 $ 82.8 $ 0.90 Special items, after tax (Attachment 3) 79.3 0.86 116.2 1.26 Amortization expense, after-tax 61.5 0.67 49.0 0.53 Adjusted net income / EPS $ 216.6 $ 2.36 $ 248.0 $ 2.69 (1) Per share amounts may not recalculate from figures presented herein due to rounding 7 Attachment 2 Avient Corporation Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Three Months Ended December 31, Year Ended December 31, 2023 2022 2023 2022 Sales $ 719.0 $ 790.4 $ 3,142.8 $ 3,396.9 Cost of sales 510.1 618.4 2,250.3 2,514.2 Gross margin 208.9 172.0 892.5 882.7 Selling and administrative expense 165.8 171.6 695.7 639.4 Operating income 43.1 0.4 196.8 243.3 Interest expense, net (26.8) (49.4) (115.3) (119.8) Other income (expense), net 4.3 (28.4) 5.8 (59.7) Income (loss) from continuing operations before income taxes 20.6 (77.4) 87.3 63.8 Income tax benefit (expense) 7.0 60.8 (11.0) 19.3 Net income (loss) from continuing operations 27.6 (16.6) 76.3 83.1 Income (loss) from discontinued operations, net of income taxes 0.8 561.5 (0.1) 620.3 Net income 28.4 544.9 76.2 703.4 Net loss (income) attributable to noncontrolling interests 0.2 (0.4) (0.5) (0.3) Net income attributable to Avient common shareholders $ 28.6 $ 544.5 $ 75.7 $ 703.1 Earnings (loss) per share attributable to Avient common shareholders - Basic: Continuing operations $ 0.30 $ (0.19) $ 0.83 $ 0.91 Discontinued operations 0.01 6.17 — 6.80 Total $ 0.31 $ 5.98 $ 0.83 $ 7.71 Earnings (loss) per share attributable to Avient common shareholders - Diluted: Continuing operations $ 0.30 $ (0.19) $ 0.83 $ 0.90 Discontinued operations 0.01 6.17 — 6.73 Total $ 0.31 $ 5.98 $ 0.83 $ 7.63 Cash dividends declared per share of common stock $ 0.2575 $ 0.2475 $ 1.0000 $ 0.9600 Weighted-average shares used to compute earnings per common share: Basic 91.2 91.0 91.1 91.2 Diluted 91.9 91.0 91.8 92.2 8 Attachment 3 Avient Corporation Summary of Special Items (Unaudited) (In millions, except per share data) Special items (1) Three Months Ended December 31, Year Ended December 31, 2023 2022 2023 2022 Cost of sales: Restructuring costs, including accelerated depreciation $ (2.0) $ (21.3) $ (11.9) $ (31.1) Environmental remediation costs (17.2) (0.4) (69.7) (24.2) Reimbursement of previously incurred environmental costs 1.6 — 1.6 8.3 Acquisition related costs — (23.8) — (34.1) Impact on cost of sales (17.6) (45.5) (80.0) (81.1) Selling and administrative expense: Restructuring and employee separation costs (1.1) (4.3) (14.9) (5.3) Legal and other (6.1) (4.0) (15.2) (3.0) Acquisition related costs (1.3) (6.1) (5.9) (19.3) Impact on selling and administrative expense (8.5) (14.4) (36.0) (27.6) Impact on operating income (26.1) (59.9) (116.0) (108.7) Interest expense, net - financing costs (0.1) (16.0) (2.3) (26.0) Mark-to-market on derivatives — — — (30.9) Pension and post retirement mark-to-market adjustment and other 3.8 (28.4) 3.7 (28.4) Impact on other income (expense), net 3.8 (28.4) 3.7 (59.3) Impact on income from continuing operations before income taxes (22.4) (104.3) (114.6) (194.0) Income tax benefit on above special items 4.5 26.8 27.7 49.4 Tax adjustments(2) 12.5 39.2 7.6 28.4 Impact of special items on net income from continuing operations $ (5.4) $ (38.3) $ (79.3) $ (116.2) Diluted earnings per common share impact $ (0.06) $ (0.42) $ (0.86) $ (1.26) Weighted average shares used to compute adjusted earnings per share: Diluted 91.9 91.7 91.8 92.2 (1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to- market adjustments associated with gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non- recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results Three Months Ended December 31, Year Ended December 31, 2023 2022 2023 2022 Sales: Color, Additives and Inks $ 459.4 $ 490.8 $ 2,007.4 $ 2,355.0 Specialty Engineered Materials 259.8 300.8 1,138.2 1,044.4 Corporate (0.2) (1.2) (2.8) (2.5) Sales $ 719.0 $ 790.4 $ 3,142.8 $ 3,396.9 Gross margin: Color, Additives and Inks $ 148.3 $ 134.5 $ 631.2 $ 681.3 Specialty Engineered Materials 78.1 82.4 341.8 283.7 Corporate (17.5) (44.9) (80.5) (82.3) Gross margin $ 208.9 $ 172.0 $ 892.5 $ 882.7 Selling and administrative expense: Color, Additives and Inks $ 86.5 $ 90.2 $ 371.3 $ 380.3 Specialty Engineered Materials 48.7 47.2 199.3 143.6 Corporate 30.6 34.2 125.1 115.5 Selling and administrative expense $ 165.8 $ 171.6 $ 695.7 $ 639.4 Operating income: Color, Additives and Inks $ 61.8 $ 44.3 $ 259.9 $ 301.0 Specialty Engineered Materials 29.4 35.2 142.5 140.1 Corporate (48.1) (79.1) (205.6) (197.8) Operating income $ 43.1 $ 0.4 $ 196.8 $ 243.3 13 Attachment 7 Avient Corporation Reconciliation of Non-GAAP Financial Measures (Unaudited) (In millions, except per share data) Senior management uses gross margin before special items and operating income before special items to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and how it may serve as a basis for future performance.

Fiber Reinforced Polymer Polymer Jacket Extrusion Wire & Cable Colorants: OnColor™

APPLICATIONS: Power cables, Ethernet category cables, industrial cables, solar installation cables, coaxial cables, fiber optics, hybrid cables SYNCURE™ Cross-Linked Polyethylene for Power Cable Insulation • Resistant to heat, oil, creep and abrasion • Fast extrusion speeds • UL 44 & UL 4703 flame performance • UL/CSA bulletins MAXXAM™ FR W&C Flame Retardant Polypropylene for Category Cable Insulation and Cross-Webs • Alternative to FEP • Low dielectric • Thin wall extrusion capabilities • UL 444 & plenum yellow card flame performance FIRECON™ Flame Retardant Chlorinated Polyethylene for Industrial Cable Jackets • Resistance to harsh environments • Low temperature properties • UV resistance • UL 44 flame performance ECCOH™ LSFOH Low Smoke and Fume, Non-Halogen for Insulation and Jackets • Low smoke and toxicity • Improved fire safety • Resistance to chemicals • UL44 and CPR flame performance ADDITIONAL SOLUTIONS MAXXAM™ SY Foamed Polypropylene for Coaxial Cable Insulation SYNPRENE™ Flame Retardant Thermoplastic Elastomers POLYMIX™ Customer Proprietary Formulations For more information, please visit avient.com or call +1.844.4AVIENT (+1.844.428.4368).

Excellent chemical resistance and insulation properties. Good chemical Lower density with moderate strength. Good chemical Lower density with moderate strength.

Mevopur™ Healthcare Colorants and Formulations Special Effect Colorants for Healthcare Devices and Pharmaceutical Packaging Self-administered medication, for example via pen devices and inhalers, has been the norm for many years. Ingredients used in the Mevopur™ portfolio have been tested to industry standards that support applications in both medical devices and pharmaceutical packaging.* KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified manufacturing sites, providing global consistency and increased security of supply • Documented change control beyond CAS number, reducing risk of change • Non-phthalate and formulated without animal-derived substances • Available as pre-colored formulation or concentrate and for use in different polymers REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Food contact established with FDA/EU** APPLICATION BULLETIN * Design note: Effect colors require careful consideration of part design and polymer flow paths to minimize visible flow lines.

AVINENT COLORANTS BRASIL

    CLEVELAND, Jan. 13, 2016 /PRNewswire/ -- PolyOne Corporation (NYSE: POL) a premier provider of specialized polymer material     CLEVELAND, Jan. 4, 2016 /PRNewswire/ -- PolyOne Corporation (NYSE: POL), a premier global provider of specialized polymer m Specialty acquisition broadens solutions portfolio of colorant and additives technologies for fiber applications - Extends PolyOne's existing rea

ITALIAN MOLDER & PART PRODUCER L U X U R Y T O O T H B R U S H B A S E • Density 4.0 SG • Low water absorption • Good mechanical performance • Chemical resistance to toothpaste and cleaning products • Worked in close collaboration with customer to fully understand material requirements • Provided an alternative to metal with the processing and recyclability benefits of a polymer • Enabled customer to launch innovative new product into the market winning Red Dot Design Award Gravi-Tech™ Density Modified Formulations KEY REQUIREMENTS WHY AVIENT? https://www.avient.com/products/engineered-polymer-formulations/eco-conscious-formulations/gravi-tech-density-modified-formulations Italian molder & Part producer